APA (7th ed.) Citation

Fleischer, A., Roll, M., Frenking, J., Panther, F., Gelbrich, G., Strunz, P., . . . Rasche, L. (2025). Talquetamab-related dysgeusia in multiple myeloma compared to BCMA-targeted bispecifics and high-dose melphalan. Cancer medicine, 14(23), . https://doi.org/10.1002/cam4.71401

Chicago Style (17th ed.) Citation

Fleischer, Anna, et al. "Talquetamab-related Dysgeusia in Multiple Myeloma Compared to BCMA-targeted Bispecifics and High-dose Melphalan." Cancer Medicine 14, no. 23 (2025). https://doi.org/10.1002/cam4.71401.

MLA (9th ed.) Citation

Fleischer, Anna, et al. "Talquetamab-related Dysgeusia in Multiple Myeloma Compared to BCMA-targeted Bispecifics and High-dose Melphalan." Cancer Medicine, vol. 14, no. 23, 2025, https://doi.org/10.1002/cam4.71401.